Home Delayed cord clamping in full-term neonates: is it time for outlining exclusion criteria?
Article
Licensed
Unlicensed Requires Authentication

Delayed cord clamping in full-term neonates: is it time for outlining exclusion criteria?

  • Raffaella Mormile EMAIL logo , Giorgio Vittori , Rosalba Vitale and Umberto Squarcia
Published/Copyright: October 20, 2012

Received: 2012-9-13
Accepted: 2012-9-21
Published Online: 2012-10-20
Published in Print: 2013-02-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review Article
  4. Clinical and diagnostic characteristics of hyperprolactinemia in childhood and adolescence
  5. Images in Pediatric Endocrinology
  6. Early occurrence of cerebral white matter abnormality detected in a neonate with salt-wasting congenital adrenal hyperplasia
  7. Original Articles
  8. Pentoxifylline treatment for protecting diabetic retinopaty in children with type 1 diabetes
  9. Absence of diabetes mellitus type 2 in obese children and adolescents in the north of Spain
  10. Ceramide mediates inhibition of the Akt/eNOS pathway by high levels of glucose in human vascular endothelial cells
  11. Short- and middle-term continuous use of cinacalcet in children on peritoneal dialysis
  12. Congenital hypothyroidism caused by a novel mutation of the dual oxidase 2 (DUOX2) gene
  13. Arginine-guanidinoacetate-creatine pathway in preterm newborns: creatine biosynthesis in newborns
  14. The effect of different nutritional states on puberty onset and the expression of hypothalamic Kiss1/kisspepetin
  15. Celiac disease and dermatitis herpetiformis in Brazilian twins: a long-term follow-up and screening of their relatives
  16. Glucocorticoid receptor expression in whole blood with preterm infants
  17. Trends in hospitalizations among children with type 1 diabetes in Spain, 2001–2009
  18. Effects of a combined intervention for treating severely obese prepubertal children
  19. Vitamin D levels, insulin resistance, and cardiovascular risks in very young obese children
  20. Prevalence of metabolic syndrome in children and adolescents — the recent trends in South Korea
  21. Elevated visfatin levels in obese children are related to proinflammatory factors
  22. Patient reports
  23. A clinically euthyroid child with a large goiter due to a thyroglobulin gene defect: clinical features and genetic studies
  24. Immune thrombocytopenic purpura in a child with thyroid hormone resistance – a rare presentation
  25. Attempted suicide with levothyroxine in an adolescent girl
  26. Differentiated thyroid carcinoma in a girl with resistance to thyroid hormone management with triiodothyroacetic acid
  27. Brothers with germline PTEN mutations and persistent hypoglycemia, macrocephaly, developmental delay, short stature, and coagulopathy
  28. DEND syndrome due to V59A mutation in KCNJ11 gene: unresponsive to sulfonylureas
  29. Severe short stature due to 3-M syndrome with a novel OBSL1 gene mutation
  30. Mild form of 3-methylglutaconic aciduria type IV and mutation in the TMEM70 genes
  31. Conn syndrome and Crohn disease in a pediatric case: an interesting parallel
  32. Adolescent ischemic stroke associated with anabolic steroid and cannabis abuse
  33. Anorexia nervosa in a patient with congenital adrenal hyperplasia
  34. Severe hypothalamopituitary dysfunction accompanied by influenza-associated encephalopathy: report of two pediatric cases
  35. Octreotide-induced hepatitis in a child with persistent hyperinsulinemia hypoglycemia of infancy
  36. Hepatitis in an infant treated with octreotide for congenital hyperinsulinism
  37. Letters to the Editor
  38. Delayed cord clamping in full-term neonates: is it time for outlining exclusion criteria?
  39. And what about cord blood cardiac troponin I (cTnI) levels as an inclusion criterion for therapeutic hypothermia after perinatal asphyxia?
  40. Duplication of SOX9 is not a common cause of 46,XX testicular or 46,XX ovotesticular DSD
  41. Association of the interferon-γ (IFN-γ) gene polymorphism with endometriosis: is epidermal growth factor (EGF) the key-mediator?
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0292/html
Scroll to top button